Alzheon, Inc. is a privately held clinical-stage biopharmaceutical company founded in 2013 and headquartered at 111 Speen Street, Framingham, Massachusetts, developing oral small-molecule therapeutics and diagnostics for Alzheimer's disease and other neurodegenerative disorders. - View it on GitHub